Drugs / Shensong Yangxin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01750775 | Aug 2012 → Sep 2013 | cardiac rhythm disease | kejiang Cao | Unknown | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shensong Yangxin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01750775 ↗ |
| Known as | SSYX | “A traditional Chinese medicine, Shensong Yangxin (SSYX), has been effective in treatment of frequent PVCs and sinus bradycardia (SB) in separate patient cohorts.” PMID 30949218 ↗ Mar 2019 |
| Modality | Traditional medicine (herbal / TCM) | “A traditional Chinese medicine, Shensong Yangxin (SSYX)” PMID 30949218 ↗ Mar 2019 |
| Route | Oral | “ShenSongYangXin Capsule 4 granules t.i.d. by mouth for 8 weeks” NCT01750775 ↗ |